Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378597164> ?p ?o ?g. }
- W4378597164 endingPage "25" @default.
- W4378597164 startingPage "12" @default.
- W4378597164 abstract "Glioblastoma (GBM) is one of the most malignant tumors of the central nervous system and has a poor prognosis. GBM cells are highly sensitive to ferroptosis and heat, suggesting thermotherapy-ferroptosis as a new strategy for GBM treatment. With its biocompatibility and photothermal conversion efficiency, graphdiyne (GDY) has become a high-profile nanomaterial. Here, the ferroptosis inducer FIN56 was employed to construct GDY-FIN56-RAP (GFR) polymer self-assembled nanoplatforms against GBM. GDY could effectively load FIN56 and FIN56 released from GFR in a pH-dependent manner. The GFR nanoplatforms possessed the advantages of penetrating the BBB and acidic environment-induced in situ FIN56 release. Moreover, GFR nanoplatforms induced GBM cell ferroptosis by inhibiting GPX4 expression, and 808 nm irradiation reinforced GFR-mediated ferroptosis by elevating the temperature and promoting FIN56 release from GFR. In addition, the GFR nanoplatforms were inclined to locate in tumor tissue, inhibit GBM growth, and prolong lifespan by inducing GPX4-mediated ferroptosis in an orthotopic xenograft mouse model of GBM; meanwhile, 808 nm irradiation further improved these GFR-mediated effects. Hence, GFR may be a potential nanomedicine for cancer therapy, and GFR combined with photothermal therapy may be a promising strategy against GBM." @default.
- W4378597164 created "2023-05-29" @default.
- W4378597164 creator A5002327301 @default.
- W4378597164 creator A5002884685 @default.
- W4378597164 creator A5022877821 @default.
- W4378597164 creator A5026984704 @default.
- W4378597164 creator A5041648101 @default.
- W4378597164 creator A5072409965 @default.
- W4378597164 creator A5075715258 @default.
- W4378597164 creator A5087536406 @default.
- W4378597164 creator A5089026055 @default.
- W4378597164 date "2023-07-01" @default.
- W4378597164 modified "2023-09-28" @default.
- W4378597164 title "Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma" @default.
- W4378597164 cites W1987926708 @default.
- W4378597164 cites W1997183854 @default.
- W4378597164 cites W2007185373 @default.
- W4378597164 cites W2028517578 @default.
- W4378597164 cites W2029317179 @default.
- W4378597164 cites W2035951369 @default.
- W4378597164 cites W2070240528 @default.
- W4378597164 cites W2073223588 @default.
- W4378597164 cites W2122934527 @default.
- W4378597164 cites W2264088247 @default.
- W4378597164 cites W2265062179 @default.
- W4378597164 cites W2345350059 @default.
- W4378597164 cites W2470779923 @default.
- W4378597164 cites W2547639030 @default.
- W4378597164 cites W2586389467 @default.
- W4378597164 cites W2617266043 @default.
- W4378597164 cites W2623800171 @default.
- W4378597164 cites W2731061882 @default.
- W4378597164 cites W2735946732 @default.
- W4378597164 cites W2766268596 @default.
- W4378597164 cites W2778468247 @default.
- W4378597164 cites W2788392567 @default.
- W4378597164 cites W2795028304 @default.
- W4378597164 cites W2801897467 @default.
- W4378597164 cites W2804444100 @default.
- W4378597164 cites W2890668604 @default.
- W4378597164 cites W2894668217 @default.
- W4378597164 cites W2895971888 @default.
- W4378597164 cites W2899366602 @default.
- W4378597164 cites W2900148502 @default.
- W4378597164 cites W2901748905 @default.
- W4378597164 cites W2905610837 @default.
- W4378597164 cites W2906319220 @default.
- W4378597164 cites W2907974104 @default.
- W4378597164 cites W2917563620 @default.
- W4378597164 cites W2945070460 @default.
- W4378597164 cites W2946915376 @default.
- W4378597164 cites W2955888413 @default.
- W4378597164 cites W2959194968 @default.
- W4378597164 cites W3005110988 @default.
- W4378597164 cites W3006762758 @default.
- W4378597164 cites W3019242636 @default.
- W4378597164 cites W3037039005 @default.
- W4378597164 cites W3043926967 @default.
- W4378597164 cites W3044858173 @default.
- W4378597164 cites W3082097061 @default.
- W4378597164 cites W3083603751 @default.
- W4378597164 cites W3094771195 @default.
- W4378597164 cites W3119066924 @default.
- W4378597164 cites W3123922203 @default.
- W4378597164 cites W3127461213 @default.
- W4378597164 cites W3129079324 @default.
- W4378597164 cites W3133611223 @default.
- W4378597164 cites W3134453057 @default.
- W4378597164 cites W3145360492 @default.
- W4378597164 cites W3174246647 @default.
- W4378597164 cites W3208086214 @default.
- W4378597164 cites W4200057600 @default.
- W4378597164 cites W4200327950 @default.
- W4378597164 cites W4206953829 @default.
- W4378597164 cites W4211050477 @default.
- W4378597164 cites W4220981667 @default.
- W4378597164 cites W4224981351 @default.
- W4378597164 cites W4281491902 @default.
- W4378597164 cites W4281757914 @default.
- W4378597164 cites W4281869658 @default.
- W4378597164 cites W4306658490 @default.
- W4378597164 cites W4307115665 @default.
- W4378597164 doi "https://doi.org/10.1016/j.jconrel.2023.05.035" @default.
- W4378597164 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37244298" @default.
- W4378597164 hasPublicationYear "2023" @default.
- W4378597164 type Work @default.
- W4378597164 citedByCount "0" @default.
- W4378597164 crossrefType "journal-article" @default.
- W4378597164 hasAuthorship W4378597164A5002327301 @default.
- W4378597164 hasAuthorship W4378597164A5002884685 @default.
- W4378597164 hasAuthorship W4378597164A5022877821 @default.
- W4378597164 hasAuthorship W4378597164A5026984704 @default.
- W4378597164 hasAuthorship W4378597164A5041648101 @default.
- W4378597164 hasAuthorship W4378597164A5072409965 @default.
- W4378597164 hasAuthorship W4378597164A5075715258 @default.
- W4378597164 hasAuthorship W4378597164A5087536406 @default.
- W4378597164 hasAuthorship W4378597164A5089026055 @default.
- W4378597164 hasConcept C12554922 @default.